S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Takeda PharmaceuticalRegeneron PharmaceuticalsBayer AktiengesellschaftVertex PharmaceuticalsZoetis
SymbolNYSE:TAKNASDAQ:REGNOTCMKTS:BAYRYNASDAQ:VRTXNYSE:ZTS
Price Information
Current Price$17.47$461.57$15.46$211.98$145.68
52 Week RangeBuyBuyHoldBuyBuy
MarketRank™
Overall Score2.02.61.02.42.3
Analysis Score3.54.40.04.42.3
Community Score2.12.62.33.23.2
Dividend Score3.30.02.50.01.7
Ownership Score0.01.70.01.73.3
Earnings & Valuation Score1.34.40.02.51.3
Analyst Ratings
Consensus RecommendationBuyBuyHoldBuyBuy
Consensus Price Target$30.00$625.81N/A$292.68$167.73
% Upside from Price Target71.72% upside35.58% upsideN/A38.07% upside15.13% upside
Trade Information
Market Cap$55.08 billion$49.45 billion$57.65 billion$55.11 billion$69.22 billion
Beta1.010.31.340.790.71
Average Volume4,573,8281,095,488543,1702,201,0212,106,551
Sales & Book Value
Annual Revenue$30.20 billion$7.86 billion$48.23 billion$4.16 billion$6.26 billion
Price / Sales1.826.291.2013.2411.06
Cashflow$3.34 per share$21.83 per share$3.40 per share$4.58 per share$4.14 per share
Price / Cash5.2321.144.5546.2735.17
Book Value$13.80 per share$100.56 per share$14.27 per share$23.66 per share$5.69 per share
Price / Book1.274.591.088.9625.60
Profitability
Net Income$407.02 million$2.12 billion$4.58 billion$1.18 billion$1.50 billion
EPS$1.78$21.47$1.77$4.29$3.64
Trailing P/E Ratio58.2416.87N/A26.7743.23
Forward P/E Ratio7.9813.618.0522.8235.36
P/E GrowthN/A0.826.101.254.35
Net Margins3.04%38.28%-22.32%38.51%25.50%
Return on Equity (ROE)13.46%28.97%14.23%28.55%63.89%
Return on Assets (ROA)5.02%20.11%5.01%20.68%14.99%
Dividend
Annual Payout$0.72N/A$0.53N/A$1.00
Dividend Yield4.12%N/A3.43%N/A0.69%
Three-Year Dividend Growth6.41%N/AN/AN/AN/A
Payout Ratio40.45%N/A29.94%N/A27.47%
Years of Consecutive Dividend GrowthN/AN/AN/AN/A1 Years
Debt
Debt-to-Equity Ratio0.99%0.27%1.12%0.07%2.41%
Current Ratio1.51%3.89%1.10%3.72%3.47%
Quick Ratio1.08%3.12%0.81%3.60%2.60%
Ownership Information
Institutional Ownership Percentage3.41%85.00%N/A92.17%92.50%
Insider Ownership PercentageN/A11.84%N/A0.70%0.17%
Miscellaneous
Employees47,4958,314100,6183,00010,600
Shares Outstanding3.15 billion107.13 million3.73 billion259.96 million475.17 million
Next Earnings Date5/12/2021 (Estimated)5/4/2021 (Estimated)4/26/2021 (Estimated)5/5/2021 (Estimated)5/5/2021 (Estimated)
OptionableOptionableOptionableNot OptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.